Pricing Log in Create free account

AgomAb Therapeutics NV (AGMB) vs Autolus Therapeutics PLC Sponsored ADR (AUTL)

AgomAb Therapeutics NV and Autolus Therapeutics PLC Sponsored ADR are both Biotechnology companies. AgomAb Therapeutics NV and Autolus Therapeutics PLC Sponsored ADR are of similar size ($343.3M and $335.4M). Across the 6 metrics below, AgomAb Therapeutics NV leads on 4 and Autolus Therapeutics PLC Sponsored ADR on 2.

Valuation

Metric AGMB AUTL Biotechnology median
P/E — n/m 10.60
P/S — 2.90 9.40
P/B n/m 4.55 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.83 9.02
Earnings yield — (82.81%) (32.88%)
Free cash flow yield 0.00% (74.52%) (23.13%)

Profitability

Metric AGMB AUTL Biotechnology median
Gross margin — 15.66% 68.51%
Operating margin — (210.78%) 0.00%
Net margin — (238.66%) 0.00%
Free cash flow margin 0.00% (198.26%) 0.00%
Return on equity — (133.00%) (51.96%)
Return on assets — (46.15%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AGMB AUTL Biotechnology median
Revenue growth (TTM) — 193.29% 6.76%
EPS growth (last fiscal year) (39.80%) (25.58%) 29.88%
Revenue growth, 5-year CAGR — 113.11% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AGMB AUTL Biotechnology median
Debt to equity 0.00 1.04 0.00
Current ratio 12.88 4.89 4.97
Net debt to EBITDA 1.96 1.16 1.01

Dividend

Metric AGMB AUTL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AGMB AUTL Biotechnology median
Market cap 343.27m 335.36m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack